Alice Blue Home
URL copied to clipboard

Trending News

Capital Infra Trust Invit : Capital Infra Trust Invit shares get listed at the same price as issue price at ₹99!

Capital Infra Trust InvIT listed flat on NSE and BSE at ₹99 per unit, matching its issue price, signaling balanced demand and reflecting confidence in its infrastructure-focused long-term growth potential.
Capital Infra InvIT shares listed at ₹99, same as issue price.
Capital Infra InvIT shares listed at ₹99, same as issue price.

Capital Infra Trust Invit debuted flat on NSE and BSE, listing at ₹99 per unit, matching its issue price. The steady debut reflects balanced market demand for its infrastructure-focused offerings and long-term investment potential.

Alice Blue Image

Also Read: Renewable energy stock falls 5% after its net profits decline by 16.7% in Q3

Capital Infra Trust InvIT garnered a 2.80x subscription on Day 3, indicating good investor interest. This reflects strong market confidence in the company’s growth prospects and future opportunities, signaling a reserved yet optimistic outlook on its long-term potential in the infrastructure sector.

Also Read: PSU stock jumps 6% after receiving order to supply missiles for the Indian Navy

Capital Infra Trust, established in September 2023 and sponsored by Gawar Construction, is an InvIT focused on road and highway projects across 19 states. Managing 26 projects, it boasts strong creditworthiness with a ‘Provisional CRISIL AAA/Stable’ rating.

Alice Blue Image

Capital Infra InvIT aims to provide loans to Project SPVs for repaying external borrowings, prepayment penalties, and unsecured loans from the Sponsor, ensuring debt reduction and financial stabilization for road and highway infrastructure projects.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.

Loading
Submit the form, and get to know how you scored!!!
Submit the form, and get to know how you scored!!!
Read More News
Magtein निर्माण का अनुबंध मिलने के बाद हेल्थकेयर स्टॉक 14% बढ़ा, भारतीय बाजार में उपस्थिति को मजबूत किया।

हेल्थकेयर स्टॉक 14% बढ़ा, कंपनी को भारतीय बाजार में Magtein के निर्माण के लिए नया अनुबंध मिलने के बाद।

फार्मास्युटिकल कंपनी ने Magnesium L-Threonate (Magtein®) के निर्माण, मार्केटिंग और वितरण के लिए भारत में एक्सक्लूसिव अधिकार हासिल किए हैं,

₹3,500 करोड़ की कैपेक्स सब्सिडी को मंजूरी मिलने से सेमीकंडक्टर स्टॉक 4% बढ़ा।

सेमीकंडक्टर स्टॉक 4% बढ़ा, सरकार के ₹3,500 करोड़ की कैपेक्स सब्सिडी को मंजूरी देने के बाद।

प्रमुख सेमीकंडक्टर कंपनी ने इंडिया सेमीकंडक्टर मिशन (ISM) के साथ एक फिस्कल सपोर्ट एग्रीमेंट पर हस्ताक्षर किए हैं। इस परियोजना

Open Demat Account With

Account Opening Fees!

Enjoy New & Improved Technology With
ANT Trading App!